Preliminary reports suggest conolidine might inhibit specific ion channels, reducing neuronal excitability and restricting ache indicators. This system is especially related in neuropathic suffering, in which irregular signaling triggers persistent irritation. Moreover, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral